10 news items
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
ADBE
ATI
BAND
14 Jun 24
(NYSE:TPC) rose 9.9% to $21.11. UBS analyst Steven Fisher upgraded Tutor Perini from Neutral to Buy and raised the price target from $14 to $27
Groundbreaking Study by MAIA Biotechnology (NYSE: MAIA) Indicates Promising New Treatment for Advanced Lung Cancer
CORT
HALO
MAIA
6 Jun 24
market is driven by advancements in targeted
Truist Securities Reiterates Buy on Corcept Therapeutics, Raises Price Target to $65
CORT
4 Jun 24
Truist Securities analyst Joon Lee reiterates Corcept Therapeutics (NASDAQ:CORT) with a Buy and raises the price target from $44 to $65.
Corcept Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
CORT
29 May 24
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $40.5, a high
HC Wainwright & Co. Reiterates Buy on Corcept Therapeutics, Maintains $40 Price Target
CORT
29 May 24
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Corcept Therapeutics (NASDAQ:CORT) with a Buy and maintains $40 price target.
216nsa0lt2ghfuwm6wq0l6xmkpxdf2lyrfyg3 gbad5o104f6jlizwiz
ABL
AGIO
ARCT
28 May 24
and announced a price target of $260.
HubSpot, Inc
k0xpcpt37ba01msva8vujemzvjezztc6h66m770g7o3hs565ayrktm4fa
CORT
2 May 24
0
Providing deeper insights, analysts have established 12-month price targets, indicating
eoqfc8xh9txpki asufiozj237c8
CORT
2 May 24
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Corcept Therapeutics (NASDAQ:CORT) with a Buy and raises the price target from $38 to $40.
irj54z
CORT
2 May 24
Truist Securities analyst Joon Lee maintains Corcept Therapeutics (NASDAQ:CORT) with a Buy and raises the price target from $42 to $44.
87lavehvvw59o43odgc2bebsl7g9ixs1s
CORT
23 Apr 24
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Corcept Therapeutics (NASDAQ:CORT) with a Buy and maintains $38 price target.
- Prev
- 1
- Next